查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球内视镜血管采集设备市场 - 2023-2030
市场调查报告书
商品编码
1373400

全球内视镜血管采集设备市场 - 2023-2030

Global Endoscopic Vessel Harvesting Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

大隐静脉 (GSV) 是冠状动脉绕道手术中最常用的导管，透过内视镜静脉采集 (EVH) 方法采集。利用微小切口和类似钝器解剖器的内视镜摄影机在皮肤下製作皮下组织隧道来执行此手术。该练习描述了该程序的基本步骤以及执行该程序的医疗团队的职责。

由于内视镜技术的不断发展，视觉品质、器械移动性和血管采集手术的整体有效性都得到了改善。由于这些发展，内视镜血管采集现在变得更安全、更有效率。微创外科手术的优势，例如切口更小、疤痕更少、恢復更快，正促使更多患者寻求这种手术。为了满足患者的需求，外科医生越来越多地使用内视镜血管采集装置。

市场动态：驱动因素

冠状动脉绕道手术 (CABG) 手术的需求不断增加

大隐静脉 (GSV) 是冠状动脉绕道手术 (CABG) 手术中最常用的导管，在过去十年中一直透过内视镜静脉采集 (EVH) 收集。由于隐静脉的长度和采集的简单性，隐静脉经常被利用。由于患者进行大量冠状动脉绕道手术的必要性不断增加以及全球对冠状动脉绕道手术的需求不断增加，对更多更好导管的需求也不断增长。

主要参与者正在提供产品来满足市场上设备的需求。例如，Vasoview Hemopro 2 内视镜血管采集 (EVH) 系统采用最先进的人体工学设计。它是隐静脉和桡动脉血管采集的行业标准，具有出色的可操作性和卓越的可视性，使采集器能够更有效率地工作，从而获得更好的患者治疗效果。

此外，建议在微创手术过程中使用Saphena Medical Venapax内视镜血管采集系统。主要适用于接受内视镜动脉绕道手术的患者，以取得血管。用于冠状动脉绕道手术的沿隐静脉的组织解剖和用于冠状动脉搭桥术的周边动脉绕道术或桡动脉的组织解剖是四肢手术的例子。

心血管疾病的盛行率不断增加

根据世界卫生组织的数据，心血管疾病 (CVD) 是全球死亡的主要原因，每年有 1,790 万人死亡。冠心病、脑血管疾病、风湿性心臟病和其他疾病都属于心臟和血管疾病，称为CVD。每 5 例 CVD 死亡中就有超过 4 例是由心臟病发作和中风造成的，其中三分之一的死亡发生在 70 岁之前。

此外，心血管疾病治疗的技术进步也推动了市场的发展。例如，根据《2023年可视化外科杂誌》报道，在过去的几十年里，冠状动脉手术经历了显着的发展。许多这些进展改善了患者的移植物通畅性并降低了心臟手术的发生率。机器人完全内视镜冠状动脉绕道手术（TECAB）移植是一种治疗方法，外科医生使用手术机器人完成所有主要手术过程，包括使用内视镜端口切口进行吻合缝合。

限制因素

内视镜血管采集设备市场在经历成长的同时，也面临各种可能阻碍其发展和采用的限制因素。这些因素包括设备成本高、缺乏熟练的外科医生、安全问题、替代技术、监管障碍和有限的临床证据。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品类型分類的片段
  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 冠状动脉绕道手术 (CABG) 手术的需求不断增加
      • 心血管疾病的盛行率不断增加
    • 限制
      • 成本高
      • 缺乏熟练的外科医生
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • SWOT分析
  • 专利分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按产品类型

  • EVH系统
  • 配件
  • 其他的

第 8 章：按应用

  • 冠状动脉绕道手术 (CABG)
  • 周围动脉绕道手术

第 9 章：按最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Getinge
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Spectra Group
  • Terumo Corporation
  • KARL STORZ SE & Co. KG
  • Saphena Medical
  • Medical Instruments Spa
  • Sorin Group
  • Medical Instruments Spa
  • Med Europe Srl
  • Olympus Corporation

第 13 章：附录

简介目录
Product Code: MD7172

Overview

The greater saphenous vein (GSV), the conduit most frequently utilized in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. A subcutaneous tissue tunnel is made under the skin utilizing tiny incisions and an endoscopic camera that resembles a blunt dissector to execute this surgery. The exercise describes the procedure's essential steps as well as the responsibilities of the medical team performing it.

The quality of vision, instrument mobility, and general effectiveness of vessel harvesting procedures have all increased as a result of ongoing developments in endoscopic technology. Endoscopic vessel harvesting is now safer and more efficient thanks to these developments. The perceived advantages of minimally invasive surgical procedures, such as smaller incisions, less scarring, and speedier recovery, are leading more patients to ask for them. To suit patient needs, surgeons are increasingly likely to use endoscopic vascular harvesting devices.

Market Dynamics: Drivers

Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery

The greater saphenous vein (GSV), which is the most often used conduit in coronary artery bypass graft (CABG) surgery, has been harvested via endoscopic vein harvesting (EVH) over the past ten years. Due to their length and simplicity of harvesting, the saphenous veins are frequently exploited. The need for more and better conduits has grown as a result of the rising necessity for numerous coronary artery bypass surgeries among patients and the global demand for CABG operations.

The key players are offering the product to meet the demand of devices in the market. For instance, the Vasoview Hemopro 2 Endoscopic Vessel Harvesting (EVH) System features the most advanced ergonomic design available. It is the industry standard for both saphenous vein and radial artery vessel harvesting, offering great maneuverability and superb visibility to let harvesters work more productively and effectively for better patient outcomes.

In addition, it is recommended to use the Saphena Medical Venapax endoscopic vessel harvesting system during minimally invasive surgery. Primarily for patients undergoing endoscopic surgery for artery bypass, giving access to vascular harvesting. Tissue dissection along the saphenous vein for coronary artery bypass grafting and peripheral artery bypass or radial artery for coronary artery bypass grafting are examples of extremity surgeries.

The Increasing Prevalence of Cardiovascular diseases

According to World Health Organization, with 17.9 million deaths per year, cardiovascular diseases (CVDs) are the leading cause of death worldwide. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.

In addition, the technological advances in the treatment of cardiovascular disease drive the market. For instance, as per the Journal of Visualized Surgery in 2023, Over the past few decades, coronary artery surgery has undergone significant development. Numerous of these developments have improved graft patency for patients and reduced the morbidity of cardiac surgery. Robotic completely endoscopic coronary artery bypass (TECAB) grafting is a treatment in which surgeons use a surgical robot to complete all major surgical processes, including anastomotic suturing, using endoscopic port site incisions.

Restraining Factors

The endoscopic vessel harvesting devices market, while experiencing growth, also faces various restraint factors that can hinder its development and adoption. The factors such as high cost of devices, lack of skilled surgeons, safety concerns, alternative techniques, regulatory hurdles, and limited clinical evidence.

Segment Analysis

The global endoscopic vessel harvesting devices market is segmented based on product type, application, end-user and region.

The EVH Systems segment accounted for approximately 45.8% of the market share

The greater saphenous vein (GSV), the conduit most frequently used in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. An endoscopic camera, such as a blunt dissector, must be used in conjunction with minor incisions to create a tunnel of subcutaneous tissue beneath the skin during this surgery. The activity outlines the procedure's essential steps and clarifies the roles of the healthcare team doing it.

By employing an endoscope to view the patient's body, endoscopic tools enable clinicians to carry out minimally invasive surgeries through very small incisions. When performing cardiac surgery, the VirtuoSaph Plus Endoscopic Vessel Harvesting System from Terumo is utilized to remove the patient's saphenous vein or radial artery for use as a bypass graft.

Geographical Penetration

North America segment accounted for approximately 38.6% of the market share

North America has been a dominant force in the global endoscopic vessel harvesting devices market. Infections at the sternal or conduit harvest site incisions were thought to have occurred in between 2% and 20% of coronary artery bypass grafting (CABG) surgeries performed in the United States. Although graft harvest site infections may be more frequent after CABG, deep chest infections and mediastinitis have received a lot of attention due to their potential for significant morbidity and mortality.

Gintage offers Early generation EVH users were taken into consideration during the design of the Vasoview 7xB Endoscopic Vessel Harvesting System. The 7xB platform, with its cutting-edge, responsive controls, enables you to work with confidence and enjoy quick productivity if you are most comfortable using a two-handed configuration.

As of July 2023, CardioPrecision, an expert in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, has taken another significant step by entering the US market, which is currently the largest medical device market by value in the world and represents a significant scale up for the company. This comes after its CoreVista devices were proven to be highly effective in Scotland.

CardioPrecision, a company that was spun off from the NHS through InnoScot Health, recently debuted its technology at the prestigious Massachusetts General Hospital in Boston for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) operations.

COVID-19 Impact Analysis:

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global endoscopic vessel harvesting devices market. In order to conserve resources and reduce the risk of infection for both patients and healthcare professionals during the height of the epidemic, numerous hospitals and healthcare facilities postponed or cancelled elective surgery.

As a result, there were significantly fewer procedures involving coronary artery bypass grafting (CABG), which in turn reduced the demand for endoscopic vascular harvesting equipment.

Competitive Landscape

The major global players in the market include: Getinge, Spectra Group, Terumo Corporation, KARL STORZ SE & Co. KG, Saphena Medical, Medical Instruments Spa, Sorin Group, Medical Instruments Spa, Med Europe S.r.l., and Olympus Corporation among others.

Why Purchase the Report?

  • To visualize the global endoscopic vessel harvesting devices market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of endoscopic vessel harvesting devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global endoscopic vessel harvesting devices market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-user
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery
      • 4.1.1.2. The Increasing Prevalence of Cardiovascular Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
      • 4.1.2.2. Lack of Skilled Surgeons
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. SWOT Analysis
  • 5.7. Patent Analysis
  • 5.8. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. EVH Systems*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Accessories
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Coronary Artery Bypass Grafting (CABG)*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Peripheral Artery Bypass Surgery

9. By End-user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 9.1.2. Market Attractiveness Index, By End-user
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Getinge*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Spectra Group
  • 12.3. Terumo Corporation
  • 12.4. KARL STORZ SE & Co. KG
  • 12.5. Saphena Medical
  • 12.6. Medical Instruments Spa
  • 12.7. Sorin Group
  • 12.8. Medical Instruments Spa
  • 12.9. Med Europe S.r.l.
  • 12.10. Olympus Corporation

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us